1-(4-Bromobenzoyl)-2-phenylpyrrolidine-2-carboxamide

In the title compound, C18H17BrN2O2, which is a potential human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase inhibitor, the pyrrolidine ring exhibits an envelope conformation. In the crystal structure, intermolecular N—H...O hydrogen bonds [N...O = 2.861 (3) ] link the molecules into centrosymmetric dimers.